Get started
Author

Koji Mitsuzuka

A Specific Microdomain (“Glycosynapse 3”) Controls Phenotypic Conversion and Reversion of Bladder Cancer Cells through GM3-mediated Interaction of α3β1 Integrin with CD9
2005 · Koji Mitsuzuka, Kazuko Handa, et al. · Journal of Biological Chemistry · 115
PDF
Identification of factors associated with postoperative febrile urinary tract infection after ureteroscopy for urinary stones
2015 · Koji Mitsuzuka, Osamu Nakano, et al. · Urolithiasis · 96
Metabolic changes in patients with prostate cancer during androgen deprivation therapy
2017 · Koji Mitsuzuka, Yoichi Arai · International Journal of Urology · 84
Human α2,3-Sialyltransferase (ST3Gal II) Is a Stage-specific Embryonic Antigen-4 Synthase
2003 · Seiichi Saito, Hiroshi Aoki, et al. · Journal of Biological Chemistry · 77
PDF
18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status
2019 · Yuta Tezuka, Yuto Yamazaki, et al. · Hypertension · 72
PDF
Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan
2018 · Teppei Okamoto, Shingo Hatakeyama, et al. · World Journal of Urology · 65
An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis
2017 · Tomokazu Ishikawa, Tohru Yoneyama, et al. · International Journal of Molecular Sciences · 59
PDF
Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer
2018 · Shusuke Akamatsu, Masashi Kubota, et al. · European Urology Oncology · 53
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis
2016 · Takuma Narita, Takuya Koie, et al. · Medical Oncology · 48
Pathological and biochemical outcomes after radical prostatectomy in men with low‐risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria
2013 · Koji Mitsuzuka, Shintaro Narita, et al. · British Journal of Urology · 48
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients
2020 · Masaki Shiota, Naoki Terada, et al. · Cancer Science · 47
PDF
Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer
2015 · K Mitsuzuka, A Kyan, et al. · Prostate Cancer and Prostatic Diseases · 43
Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma
2020 · Tomonori Sato, Yoshihide Kawasaki, et al. · Metabolites · 41
PDF
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer
2019 · Itsuto Hamano, Shingo Hatakeyama, et al. · World Journal of Urology · 38
Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma
2016 · Shinichi Yamashita, Akihiro Ito, et al. · International Journal of Urology · 38
Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma
2018 · Shinya Takasaki, Yoshihide Kawasaki, et al. · International Journal of Clinical Oncology · 37
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy
2014 · Takuya Koie, Koji Mitsuzuka, et al. · International Journal of Clinical Oncology · 37
Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
2021 · Tohru Yoneyama, Hayato Yamamoto, et al. · The Prostate · 35
Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma
2019 · Tomonori Sato, Yoshihide Kawasaki, et al. · International Journal of Cancer · 35
Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection
2019 · Tohru Yoneyama, Yuki Tobisawa, et al. · Cancer Science · 31
PDF
Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of β1,4GalNAc transferase
2004 · Hiroshi Aoki, Makoto Satoh, et al. · FEBS Letters · 31
Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration‐sensitive prostate cancer: A multicenter retrospective study
2020 · Shingo Hatakeyama, Shintaro Narita, et al. · International Journal of Urology · 30
Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma
2020 · Tomonori Sato, Yoshihide Kawasaki, et al. · Cancer Science · 30
PDF
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan
2020 · Shintaro Narita, Shingo Hatakeyama, et al. · International Journal of Clinical Oncology · 30
Long‐term quality of life after radical prostatectomy: 8‐Year longitudinal study in J apan
2014 · Shunichi Namiki, Yasuhiro Kaiho, et al. · International Journal of Urology · 27
PDF
Works count: 221
Citation count: 2,297
H-index: 26
I10-index: 70
Year
Topic
Type